Global Neurostimulation Systems Market Insights, Forecast to 2028

Neurostimulation Systems
Market Analysis and Insights: Global Neurostimulation Systems Market
Due to the COVID-19 pandemic, the global Neurostimulation Systems market size is estimated to be worth US$ 7454.1 million in 2022 and is forecast to a readjusted size of US$ 14000 million by 2028 with a CAGR of 11.1% during the review period. Fully considering the economic change by this health crisis, Spinal Cord Stimulation accounting for % of the Neurostimulation Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Chronic Pain segment is altered to an % CAGR throughout this forecast period.
China Neurostimulation Systems market size is valued at US$ million in 2021, while the US and Europe Neurostimulation Systems are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Neurostimulation Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Neurostimulation Systems include Abbott Laboratories, NALU MEDICAL, Boston Scientific, Medtronic, Nevro, Nuvectra, PINS Medical, SceneRay and Stimwave LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Neurostimulation Systems Scope and Segment
Neurostimulation Systems market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Neurostimulation Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Peripheral Nerve Stimulator
Segment by Application
Chronic Pain
Parkinson’s Disease
Others
By Company
Abbott Laboratories
NALU MEDICAL
Boston Scientific
Medtronic
Nevro
Nuvectra
PINS Medical
SceneRay
Stimwave LLC
Bioventus Inc
SPR Therapeutics, Inc
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Frequently Asked Questions